T1	Participants 131 147	prostate cancer.
T2	Participants 251 291	patients with high-risk prostate cancer.
T3	Participants 314 366	Between January 2003 and December 2007, 168 patients
T4	Participants 622 784	All patients had undergone a 9-month course of total androgen deprivation, with radiotherapy starting 2 months after initiation of the total androgen deprivation.
